Target intelligence / Profile preview

Plasmodium apicoplast 50S ribosomal subunit (Apicoplast 50S ribosome)

Target
Apicoplast 50S ribosome
Molecular classification
Riboprotein complex, Ribosome, Large ribosomal subunit
01

Overview

The Plasmodium apicoplast 50S ribosomal subunit is a key component of the translation machinery located within the apicoplast, a non-photosynthetic plastid essential for the survival of malaria-causing parasites (Wilson et al., 1996). As the apicoplast is of endosymbiotic origin, its 50S subunit is structurally similar to bacterial ribosomes and significantly different from the human 80S cytosolic ribosome, providing a basis for selective toxicity (Dahl and Rosenthal, 2007). This subunit facilitates the synthesis of proteins required for the maintenance of the apicoplast and its metabolic pathways, such as the non-mevalonate pathway for isoprenoid precursor biosynthesis (Botté et al., 2012). Inhibition of this target by antibiotics like clindamycin or azithromycin disrupts these vital processes, leading to parasite death (Goodman et al., 2007). A unique feature of targeting this subunit is the "delayed death" phenomenon, where the immediate progeny of treated parasites appear viable but fail to survive subsequent replication cycles (Dahl and Rosenthal, 2007). Consequently, drugs hitting this target are often used in combination therapies to ensure rapid clearance of the infection while preventing resistance.

Other names
Apicoplast large ribosomal subunitPlasmodium falciparum apicoplast 50S ribosomeApicoplast 50S subunitApicoplast 50S ribosomal complex
02

Mechanism of action

Inhibition of protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, thereby blocking the peptidyl transferase center or preventing the translocation of the nascent peptide chain (Dahl and Rosenthal, 2007; Goodman et al., 2007).

03

Biological functions

Protein synthesisTranslationApicoplast biogenesisIsoprenoid precursor biosynthesis regulation
04

Disease associations

MalariaInfection
05

Safety considerations

Delayed death phenotypeSlow onset of actionPotential for drug resistanceLimited efficacy as monotherapy in acute malaria
06

Interacting drugs

Clindamycin

5 more in the full profile.

07

Biomarkers

Parasitemia levelsApicoplast-to-nucleus genome ratio

Beyond the preview

Go deeper on Plasmodium apicoplast 50S ribosomal subunit (Apicoplast 50S ribosome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium apicoplast 50S ribosomal subunit (Apicoplast 50S ribosome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call